Glycogen phosphorylase inhibition as a therapeutic target: a review of the recent patent literature

By Baker David J   Greenhaff Paul L   Timmons James A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 459-466

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Glycogen Phosphorylase in the Context of Type 2 Diabetes, with Focus on Recent Inhibitors Bound at the Active Site

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 12, 2010-10 ,pp. : 1102-1126

Bentham Science Publishers

Access to resources Recommend Favorite

Indirubin-3-Aminooxy-Acetate Inhibits Glycogen Phosphorylase by Binding at the Inhibitor and the Allosteric Site. Broad Specificities of the Two Sites

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 5, 2005-08 ,pp. : 377-390

Bentham Science Publishers

Access to resources Recommend Favorite

Glycogen Phosphorylase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 845-857

Bentham Science Publishers

Access to resources Recommend Favorite

The Prototype of Glycogen Phosphorylase

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 12, 2010-10 ,pp. : 1093-1101

Bentham Science Publishers

Access to resources Recommend Favorite